Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72


Circulating MIR148A associates with sensitivity to adiponectin levels in human metabolic surgery for weight loss

Ariza-Nieto M, Alley JB, Samy S, Fitzgerald L, Vermeylen F, Shuler ML, Alemán JO.

Endocr Connect. 2018 Sep 1;7(9):975-982. doi: 10.1530/EC-18-0205.


Circulating miR-148a associates with sensitivity to adiponectin levels in human metabolic surgery for weight loss.

Ariza-Nieto M, Alley JB, Samy S, Fitzgerald L, Vermeylen F, Shuler ML, Aleman JO.

Endocr Connect. 2018 Aug 2. pii: EC-18-0205. doi: 10.1530/EC-18-0205. [Epub ahead of print]


Body weight, insulin resistance, and serum adipokine levels 2 years after 2 types of bariatric surgery.

Trakhtenbroit MA, Leichman JG, Algahim MF, Miller CC 3rd, Moody FG, Lux TR, Taegtmeyer H.

Am J Med. 2009 May;122(5):435-42. doi: 10.1016/j.amjmed.2008.10.035.


Weight loss and changes in salivary ghrelin and adiponectin: comparison between sleeve gastrectomy and Roux-en-Y gastric bypass and gastric banding.

Benedix F, Westphal S, Patschke R, Granowski D, Luley C, Lippert H, Wolff S.

Obes Surg. 2011 May;21(5):616-24. doi: 10.1007/s11695-011-0374-5.


Serial changes in inflammatory biomarkers after Roux-en-Y gastric bypass surgery.

Miller GD, Nicklas BJ, Fernandez A.

Surg Obes Relat Dis. 2011 Sep-Oct;7(5):618-24. doi: 10.1016/j.soard.2011.03.006. Epub 2011 Mar 24.


Circulating concentrations of high-molecular-weight adiponectin are increased following Roux-en-Y gastric bypass surgery.

Swarbrick MM, Austrheim-Smith IT, Stanhope KL, Van Loan MD, Ali MR, Wolfe BM, Havel PJ.

Diabetologia. 2006 Nov;49(11):2552-8. Epub 2006 Sep 21.


Effects of Roux-en-Y gastric bypass on fasting and postprandial inflammation-related parameters in obese subjects with normal glucose tolerance and in obese subjects with type 2 diabetes.

Lindegaard KK, Jorgensen NB, Just R, Heegaard PM, Madsbad S.

Diabetol Metab Syndr. 2015 Feb 24;7:12. doi: 10.1186/s13098-015-0012-9. eCollection 2015.


Plasma acylation-stimulating protein, adiponectin, leptin, and ghrelin before and after weight loss induced by gastric bypass surgery in morbidly obese subjects.

Faraj M, Havel PJ, Phélis S, Blank D, Sniderman AD, Cianflone K.

J Clin Endocrinol Metab. 2003 Apr;88(4):1594-602.


Reduced cardiovascular risk following bariatric surgeries is related to a partial recovery from "adiposopathy".

Appachi S, Kelly KR, Schauer PR, Kirwan JP, Hazen S, Gupta M, Kashyap SR.

Obes Surg. 2011 Dec;21(12):1928-36. doi: 10.1007/s11695-011-0447-5.


Outcomes of Roux-en-Y gastric bypass and laparoscopic adjustable gastric banding.

Nguyen NQ, Game P, Bessell J, Debreceni TL, Neo M, Burgstad CM, Taylor P, Wittert GA.

World J Gastroenterol. 2013 Sep 28;19(36):6035-43. doi: 10.3748/wjg.v19.i36.6035.


Urinary albumin excretion, HMW adiponectin, and insulin sensitivity in type 2 diabetic patients undergoing bariatric surgery.

Navaneethan SD, Kelly KR, Sabbagh F, Schauer PR, Kirwan JP, Kashyap SR.

Obes Surg. 2010 Mar;20(3):308-15. doi: 10.1007/s11695-009-0026-1.


Postprandial adiponectin levels are associated with improvements in postprandial triglycerides after Roux-en-Y gastric bypass in type 2 diabetic patients.

Umeda LM, Pereira AZ, Carneiro G, Arasaki CH, Zanella MT.

Metab Syndr Relat Disord. 2013 Oct;11(5):343-8. doi: 10.1089/met.2012.0042. Epub 2013 Jun 7.


Energy Metabolic Adaptation and Cardiometabolic Improvements One Year After Gastric Bypass, Sleeve Gastrectomy, and Gastric Band.

Tam CS, Redman LM, Greenway F, LeBlanc KA, Haussmann MG, Ravussin E.

J Clin Endocrinol Metab. 2016 Oct;101(10):3755-3764. Epub 2016 Aug 4.


Adiponectin downregulates hyperglycemia and reduces pancreatic islet apoptosis after roux-en-y gastric bypass surgery.

Chai F, Wang Y, Zhou Y, Liu Y, Geng D, Liu J.

Obes Surg. 2011 Jun;21(6):768-73. doi: 10.1007/s11695-011-0357-6.


Effects of postbariatric surgery weight loss on adipokines and metabolic parameters: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy--a prospective randomized trial.

Woelnerhanssen B, Peterli R, Steinert RE, Peters T, Borbély Y, Beglinger C.

Surg Obes Relat Dis. 2011 Sep-Oct;7(5):561-8. doi: 10.1016/j.soard.2011.01.044. Epub 2011 Mar 22.


Omentectomy added to Roux-en-Y gastric bypass surgery: a randomized, controlled trial.

Dillard TH, Purnell JQ, Smith MD, Raum W, Hong D, Laut J, Patterson EJ.

Surg Obes Relat Dis. 2013 Mar-Apr;9(2):269-75. doi: 10.1016/j.soard.2011.09.027. Epub 2011 Oct 19.


Genes and networks expressed in perioperative omental adipose tissue are correlated with weight loss from Roux-en-Y gastric bypass.

Kim K, Perroud B, Espinal G, Kachinskas D, Austrheim-Smith I, Wolfe BM, Warden CH.

Int J Obes (Lond). 2008 Sep;32(9):1395-406. doi: 10.1038/ijo.2008.106. Epub 2008 Jul 22.


Circulating Apolipoprotein A-IV presurgical levels are associated with improvement in insulin sensitivity after Roux-en-Y gastric bypass surgery.

Rao R, Roche A, Febres G, Bessler M, Tso P, Korner J.

Surg Obes Relat Dis. 2017 Mar;13(3):468-473. doi: 10.1016/j.soard.2016.10.019. Epub 2016 Oct 26.


Preoperative assessment of gut hormones does not correlate to weight loss after Roux-en-Y gastric bypass surgery.

Werling M, Fändriks L, Vincent RP, Cross GF, le Roux CW, Olbers T.

Surg Obes Relat Dis. 2014 Sep-Oct;10(5):822-8. doi: 10.1016/j.soard.2014.04.018. Epub 2014 Apr 29. Erratum in: Surg Obes Relat Dis. 2015 Nov-Dec;11(6):1412. Royce, Vincent P [corrected to Vincent, Royce P].


The early effect of the Roux-en-Y gastric bypass on hormones involved in body weight regulation and glucose metabolism.

Rubino F, Gagner M, Gentileschi P, Kini S, Fukuyama S, Feng J, Diamond E.

Ann Surg. 2004 Aug;240(2):236-42.

Supplemental Content

Support Center